The ESMO Congress is a highly influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. The community meets to discuss latest advances and the outlook ahead.

It is an interesting time to take stock and reflect on how oncology is evolving. Here, we take the pulse of the latest oncology trends at ESMO Congress 2023 which took place in Madrid on 20-24 October 2023. 

Our four key takeaways are:

  • Strong presence and readouts for ADCs
  • Promising data on bispecific T-cell engagers
  • Advancement in I/O combination therapies
  • PD-X agents moving into earlier lines of treatment

Anne Dhulesia and Sean Dyson are Partners based in our European Life Sciences team. They support oncology players on a number of key strategic topics: BD support (screening and opportunity evaluation), portfolio planning, R&D strategy, and commercial strategy including launch preparation.

Download your copy of our detailed insights here.

L.E.K. Consulting is a registered trademark of L.E.K. Consulting. All other products and brands mentioned in this document are properties of their respective owners. © 2023 L.E.K. Consulting 

Related Insights